Studies evaluating the association between circulating sclerostin levels and mortality in CKD have yielded inconsistent results, with some investigators reporting high circulating sclerostin levels to associate with better survival [85, 98] and other investigators reporting an inverse [99] or no association [100, 101]. Here, SOST is linked to chronic kidney disease.